Table 1: Performance for Cancer medication recommendations. The best result per metric is markedin boldface. We present avg Â± stdev values for all experiments averaged over 10 independent runs.
Table 2: Performance for Cancer medication recommendation considering negative impacts from twofactors: the tumor size in the end and the ever experienced maximum toxicity.
Table 3: Evaluating the clinical efficacy (survival rate) achieved by the proposed preference-basedRL framework when hand-crafted and preference-based rewards are linear combined with differentratios.
Table 4: Configurations for Sepsis treatment simulation. h represents hour in the simulation platform.
